Table 1.
Correlation Between MFN1 Expression and the Clinicopathological Characteristics of Patients with LAD
| Clinicopathological Characteristics | Case | MFN1 Expression | P-values |
|---|---|---|---|
| High (%) Low (%) | |||
| 40 | 22 (55.00) 18 (45.00) | ||
| Gender | 0.676 | ||
| Male | 23 | 12 (52.17) 11 (47.83) | |
| Female | 17 | 10 (58.82) 7 (41.18) | |
| Age (years) | 0.243 | ||
| <60 | 16 | 7 (43.75) 9 (56.25) | |
| ≥60 | 24 | 15 (62.50) 9 (37.50) | |
| Smoking History | 0.145 | ||
| Yes | 13 | 5 (38.46) 8 (61.54) | |
| No | 27 | 17 (62.96) 10 (37.04) | |
| Differentiation | 0.071 | ||
| Well | 12 | 4 (33.33) 8 (66.67) | |
| Moderate to poor | 28 | 18 (64.29) 10 (35.71) | |
| With Diabetes Mellitus | 0.011* | ||
| Yes | 20 | 15 (75.00) 5 (25.00) | |
| No | 20 | 7 (35.00) 13 (65.00) | |
| TNM Stage | 0.028* | ||
| I+II | 19 | 7 (36.84) 12 (63.16) | |
| III+IV | 21 | 15 (71.43) 6 (28.57) | |
| Lymph Node Metastasis | 0.436 | ||
| Positive | 24 | 12 (50.00) 12 (50.00) | |
| Negative | 16 | 10 (62.50) 6 (37.50) |
Note: *P<0.05.
Abbreviations: LAD, lung adenocarcinoma; MFN1, mitofusin1; TNM, tumor node metastasis.